# Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia

> **NCT00690365** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 576 (actual)

## Conditions studied

- Schizophrenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00690365
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 576 (ACTUAL)
- **Last updated:** 2010-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00690365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00690365, "Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00690365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*